FQ
| Code | Size | Price |
|---|
| TAR-T27358-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T27358-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T27358-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
FQ is a novel reversible inhibitor of mixed-type tyrosinase.
CAS:
190838-76-7
Formula:
C14H9FN2O
Molecular Weight:
240.237
Purity:
0.98
SMILES:
Oc1nc(nc2ccccc12)-c1ccc(F)cc1
References
1. Luiz GO, Benevides RS, Santos FGS, Espinel YAV, Mayer Alegre TP, Wiederhecker GS. Efficient anchor loss suppression in coupled near-field optomechanical resonators. Opt Express. 2017 Dec 11;25(25):31347-31361. doi: 10.1364/OE.25.031347. PubMed PMID: 29245810.
2. Li Q, Li X, Deng CL. Induction of proliferation and activation of rat hepatic stellate cells via high glucose and high insulin. Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5420-5429. doi: 10.26355/eurrev_201712_13930. PubMed PMID: 29243785.
3. Arcuri L, Novello S, Frassineti M, Mercatelli D, Pisan? CA, Morella I, Fasano S, Journigan BV, Meyer ME, Polgar WE, Brambilla R, Zaveri NT, Morari M. Antiparkinsonian and antidyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists. Br J Pharmacol. 2017 Dec 12. doi: 10.1111/bph.14123. [Epub ahead of print] PubMed PMID: 29232769.
4. Zaveri NT, Marquez PV, Meyer ME, Polgar WE, Hamid A, Lutfy K. A novel and selective nociceptin receptor (NOP) agonist (1-(1-((cis)-4-isopropylcyclohexyl)piperidin-4-yl)-1H-indol-2-yl)methanol (AT-312) decreases acquisition of ethanol-induced conditioned place preference in mice. Alcohol Clin Exp Res. 2017 Dec 7. doi: 10.1111/acer.13575. [Epub ahead of print] PubMed PMID: 29215139.